That puts about $15+MM directly into the operation coffers. When this stuff gets its IND, its off the charts. Amgen is smart, they have the rights to "Pick" three solid tumors they want indication to treat. That leavs many more indication left for others to come in and pick up another partnership.
Breats, colon, prostate are the big ones to treat. Then you have skin, eye, brain, most anywhere. Cancer really sucks. Got two in the family fighting this stuff today. Thats new since I first found MITI. One day! I pray.
Market Data 
Markets 
AI
